Sanci Lena A, Sawyer Susan M, Kang Melissa S-L, Haller Dagmar M, Patton George C
Department of General Practice, University of Melbourne, Melbourne, VIC.
Med J Aust. 2005 Oct 17;183(8):410-4. doi: 10.5694/j.1326-5377.2005.tb07104.x.
Community debate about confidential health care for adolescents was triggered recently by the federal government's proposal to allow parents of teenagers aged 16 years and under access to their children's Health Insurance Commission data without their consent. Extensive research evidence highlights the importance of confidentiality in promoting young people's access to health care, particularly for sensitive issues such as mental and sexual health, and substance use. Involving parents is important, but evidence for any benefit from mandatory parental involvement is lacking. The law recognises the rights of mature minors to make decisions about their medical treatment and to receive confidential health care; however, the doctor must weigh up certain factors to assess maturity and ensure that confidentiality around such treatment will be in the young person's best interests. Evaluation of maturity must take into account characteristics of the young person, gravity of the proposed treatment, family factors, and statutory restrictions.
最近,联邦政府提议允许16岁及以下青少年的父母在未经子女同意的情况下获取其医疗保险委员会的数据,这引发了社区关于青少年保密医疗保健的辩论。大量研究证据凸显了保密在促进年轻人获得医疗保健方面的重要性,尤其是对于诸如心理和性健康以及药物使用等敏感问题。让父母参与很重要,但缺乏强制父母参与能带来任何益处的证据。法律承认成熟未成年人有权就其医疗治疗做出决定并接受保密医疗保健;然而,医生必须权衡某些因素以评估其成熟度,并确保围绕此类治疗的保密性符合年轻人的最大利益。对成熟度的评估必须考虑年轻人的特征、拟议治疗的严重性、家庭因素和法定限制。